LEADER 01316nam2-2200421---450-
001 990003203920203316
005 20150123124349.0
010   $a978-3-540-79884-2
035   $a000320392
035   $aUSA01000320392
035   $a(ALEPH)000320392USA01
035   $a000320392
100   $a20090310h2009----km-y0itay50------ba
101 0 $aeng
102   $aDE
105   $aa|||||||001yy
200 1 $aAquaporins$fEric Beitz editor$gcontributors P. Agre ...[et al.]
210   $aBerlin$cSpringer$d2009
215   $aXVI, 424 p.$d24 cm
225 2 $aHandbook of experimental pharmacology$v190
410  0$1001000320432$12001$aHandbook of experimental pharmacology$v, 190
606 0 $aAcquaporine$2BNCF
676   $a572.69
702  1$aBEITZ,$bEric
801  0$aIT$bsalbc$gISBD
912   $a990003203920203316
951   $a572.69 AQU$b5101 Farm.$c572.69 AQU$d00197677
959   $aBK
969   $aFAR
979   $aCHIARA$b90$c20090310$lUSA01$h1507
979   $aCHIARA$b90$c20090310$lUSA01$h1508
979   $aCHIARA$b90$c20090310$lUSA01$h1537
979   $aCHIARA$b90$c20090311$lUSA01$h1203
979   $aCHIARA$b90$c20090311$lUSA01$h1204
979   $aPATRY$b90$c20150123$lUSA01$h1243
979   $aPATRY$b90$c20150123$lUSA01$h1243
996   $aAquaporins$91015522
997   $aUNISA